Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,520.00
(
0.00%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
99.72
(
3.02%
)
Bitcoin
70,750.00
(
-0.21%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: caravon post# 177049

Tuesday, 04/22/2014 1:46:41 PM

Tuesday, April 22, 2014 1:46:41 PM

Post# of 257273
Re: ENTA’s pre-commercial milestone payments from ABBV

Following up on #msg-100880621, we know from ENTA’s PR today (http://finance.yahoo.com/news/enanta-pharmaceuticals-announces-drug-application-125300789.html ) that ENTA received $20M of the $40M in submission-based milestone payments today with the filing of the US NDA and will receive the other $20M when the European MAA is submitted in early May.

Regarding the $155M in milestone payments for regulatory approvals of the 3-DAA regimen, ENTA hasn’t disclosed the split between the US, EU, and other jurisdictions, but it’s reasonable to infer that roughly $75M is for the US, $75M for the EU, and $5M for other jurisdictions.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today